Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers.
about
Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters.Impact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs.Physiologically based pharmacokinetic modelling and in vivo [I]/K(i) accurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate.Assessment of Clinical Practices for Crushing Medication in Geriatric Units.Digoxin pharmacokinetics and MDR1 genetic polymorphisms
P2860
Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Pharmacokinetic and pharmacody ...... olymer, in healthy volunteers.
@ast
Pharmacokinetic and pharmacody ...... olymer, in healthy volunteers.
@en
type
label
Pharmacokinetic and pharmacody ...... olymer, in healthy volunteers.
@ast
Pharmacokinetic and pharmacody ...... olymer, in healthy volunteers.
@en
prefLabel
Pharmacokinetic and pharmacody ...... olymer, in healthy volunteers.
@ast
Pharmacokinetic and pharmacody ...... olymer, in healthy volunteers.
@en
P2093
P2860
P1476
Pharmacokinetic and pharmacody ...... olymer, in healthy volunteers.
@en
P2093
I Ragueneau
J M Poirier
N Radembino
P2860
P304
P356
10.1046/J.1365-2125.1999.00025.X
P407
P577
1999-09-01T00:00:00Z